Literature DB >> 8539401

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

J W Chung1, J H Park, J K Han, B I Choi, M C Han, H S Lee, C Y Kim.   

Abstract

PURPOSE: To elucidate major complications and their predisposing factors in transcatheter oily chemoembolization (TOCE) for hepatic tumors.
MATERIALS AND METHODS: In a retrospective study of 351 patients (aged 26-82 years) with hepatic tumors, TOCE was performed 942 times with an emulsion of iodized oil (3-40 mL) and doxorubicin hydrochloride (20-60 mg). In 126 patients, TOCE was followed by absorbable gelatin sponge embolization.
RESULTS: Complications were severe postembolization syndrome (n = 53); hepatic insufficiency (n = 20), infarction (n = 1), or abscess (n = 1); intrahepatic biloma formation (n = 3); tumor rupture (n = 3); septicemia (n = 9); coagulopathy (n = 1); gastrointestinal bleeding (n = 10); gallbladder (n = 5) or splenic infarction (n = 4); pulmonary oil embolism (n = 6); and spinal cord injury (n = 1). Important predisposing factors were major portal vein obstruction, compromised hepatic functional reserve, biliary obstruction, previous biliary surgery, excessive amount (> 20 mL) of iodized oil, hepatic arterial occlusion after repeated TOCE, and nonselective embolization.
CONCLUSION: Most patients with major complications after TOCE had preexisting risk factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8539401     DOI: 10.1148/radiology.198.1.8539401

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  70 in total

1.  Antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: a meta-analysis.

Authors:  Jun Wang; Xiao Dong He; You Cheng Zhang
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

2.  Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome.

Authors:  Sabeen Dhand; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

3.  Management of biliopleural fistula after transarterial chemoembolization of a liver lesion.

Authors:  Amir Shahzad Butt; Ghulam Mujtaba; Sury Anand; Mahesh Krishnaiah
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

4.  Prophylactic antibiotic guidelines in modern interventional radiology practice.

Authors:  Eunice Moon; Matthew D B S Tam; Raghid N Kikano; Karunakaravel Karuppasamy
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

5.  Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.

Authors:  Qizhe Sun; Wenli Ma; Yuan Gao; Wenling Zheng; Bao Zhang; Yifei Peng
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-12-29

6.  Complications of hepatic chemoembolization.

Authors:  Timothy W I Clark
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

Review 7.  Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects.

Authors:  S E Cohen; R Safadi; A Verstandig; A Eid; T Sasson; L Symmer; D Shouval
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 8.  Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

Authors:  Xavier Adhoute; Guillaume Penaranda; Paul Castellani; Herve Perrier; Marc Bourliere
Journal:  World J Hepatol       Date:  2015-03-27

9.  Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Authors:  Diane K Reyes; Josephina A Vossen; Ihab R Kamel; Nilofer S Azad; Tamara A Wahlin; Michael S Torbenson; Michael A Choti; Jean-Francois H Geschwind
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

10.  Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Vladimir Marquez; Marie-Pierre Sylvestre; Claire Wartelle-Bladou; Louis Bouchard; Pierre Perrault; Philippe Grégoire; Gilles Pomier-Layrargues
Journal:  J Gastrointest Oncol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.